Mental health, maternal bonding and parenting stress in women attending a specialist perinatal drug health service by Hutchinson, Delyse et al.
 DRO  
Deakin Research Online, 
Deakin University’s Research Repository  Deakin University CRICOS Provider Code: 00113B 
Mental health, maternal bonding and parenting stress in women attending a specialist 
perinatal drug health service 
Citation:  
Hutchinson, Delyse, Taylor, Lee, Rapee, Ronald, Burns, Lucy and Haber, Paul 2017, Mental 
health, maternal bonding and parenting stress in women attending a specialist perinatal 
drug health service, Drug addiction, Avid Science, Telangana, India, pp. 2-37. 
URL: http://www.avidscience.com/book/drug-addiction/ 
 
 
 
 
©2017, The Authors 
Reproduced by Deakin University under the terms of the Creative Commons Attribution Licence 
 
 
 
 
 
 
Downloaded from DRO:  
http://hdl.handle.net/10536/DRO/DU:30103044 
2 3www.avidscience.com
Drug Addiction                                                       Drug Addiction
www.avidscience.com
Abstract
Background: During pregnancy and the early post-
natal period, women with a history of substance use disor-
der are at increased risk for mental health, parenting and 
mother-to-infant relational problems. To date, however, 
few studies have prospectively assessed these high-risk 
women through the perinatal period; a time critical to the 
maternal bond and offspring development.
Aim:  To prospectively examine demographics, sub-
stance use, mental health, maternal bonding and parent-
ing stress in a sample of high-risk pregnant women with 
a diagnosed history of substance use disorder during the 
perinatal period.
Methods: Participants were 36 women with a diag-
nosed history of substance use disorder who accessed 
antenatal care from a specialist perinatal and family drug 
health service (SE group) and 66 women attending the 
general antenatal clinic (comparison group) in a public 
hospital in Sydney, Australia. Interviews were conducted 
in pregnancy (trimester three) and at 12 months postpar-
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tum. Women completed an interview assessing demo-
graphics, substance use, mental health, maternal bonding 
and parenting stress.
Results: SE women were significantly more likely to 
have been younger at delivery, less educated, single, un-
employed, multiparious and of Aboriginal or Torres Strait 
Islander decent. SE women reported significantly higher 
levels of depression, anxiety and stress during pregnancy 
and 12 months postpartum. Significantly lower mother-
to-fetus bonding was reported during pregnancy among 
SE women; however, no difference in mother-to-infant 
bonding was identified at 12 months postpartum. SE 
women reported significantly higher levels of total parent-
ing stress, parent-related stress, and in particular, child-
related stress, compared to the comparison group.
Conclusion: The findings indicate that SE women 
experience psychosocial disadvantage, poorer bonding to 
their developing fetus in-utero, elevated levels of perinatal 
distress, and postnatal parenting stress. Mother-to-infant 
bonding was in the healthy range at 12 months postpar-
tum in this sample. Findings highlight the critical impor-
tance of perinatal intervention and treatment for these 
high-risk pregnant women and their offspring.
Keywords
Substance Abuse; Substance Dependence; Pregnancy; 
Bonding; Perinatal Distress; Parenting Stress
Introduction
Substance Use in Pregnancy and Parenthood
Substance use among women during pregnancy is 
common. Data from the 2013 National Drug Strategy 
Household Survey (NDSHS) show that 42% of pregnant 
women in Australia consumed alcohol whilst pregnant 
[1]. Prospective cohort data suggest that up to 7.5% of 
pregnant women continue to drink 1-2 days per week, 
and up to 2.3% drink on three or more days per week [2]. 
In regard to other substances, 15% of Australian women 
reported smoking tobacco whilst pregnant, and around 
2.2% of women used illicit drugs whilst pregnant, with 
marijuana being the most commonly used illicit drug 
[1,3]. Whilst most women who use alcohol or other drugs 
in pregnancy reduce (and often cease) substance use, a 
small proportion of women continue to use these sub-
stances at levels harmful to themselves and their develop-
ing fetus [1,4,5].
Substance use remains common in parenthood. In 
Australia, an estimated 1.4 million parents report heavy 
drinking patterns, 1.2 million parents report ‘binge’ drink-
ing monthly, and 710,000 parents report ‘binge’ drinking 
weekly [2]. National figures also show that 2.3% of chil-
dren aged 12 years or less live in a household containing 
at least one daily cannabis user, and 0.8% live in a house-
hold with an adult who uses methamphetamine in the 
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home at least on a monthly basis [6]. Furthermore, 16% 
of women with older children (6-12 years) and 5% with 
younger children (1-5 years) report current drug use [6]. 
Taken together, national databases demonstrate high rates 
of substance use in the perinatal period and into later par-
enthood. Whilst a relatively small proportion of women 
engage in very harmful patterns of substance misuse, the 
health consequences for these women and their offspring 
can be substantial [4].
Parenting, Parent-Offspring Bonding and 
Substance Misuse
Poorer quality parenting practices have been docu-
mented in parents who misuse substances. In 2008-2009, 
approximately 309,600 children in Australia were report-
ed to Community Services with concerns surrounding 
their welfare [7]. Fifty to 80% of cases involved parents 
with current substance use problems and nearly 60% had 
at least one biological parent with a history of drug or al-
cohol misuse [8]. Both licit and illicit substances have the 
effect of altering one’s state of alertness, affect regulation, 
impulse control and memory, depending on the type of 
substance ingested and the pattern of use. These effects 
can undermine a parent’s capacity to care for offspring. 
Substance misuse in the family home can result in a 
chaotic and unpredictable environment. Maternal sub-
stance dependence has been associated with a higher fre-
quency of more problematic parenting styles, including 
harsh, punitive and over controlling parenting, as well as 
being under involved, ineffective and neglectful [9,10]. 
Vacillation between such parenting approaches is com-
mon in substance-affected families, and may leave chil-
dren feeling confused and overwhelmed, increasing the 
risk for poor parent-child bonding. This is of particular 
concern when children are very young and are physically 
and emotionally dependent on their primary carers [4].
Characteristics of  Children Affected by Pre-
natal Substance Exposure
Neurobehavioural studies show that compared to 
non-substance exposed neonates, neonates prenatally ex-
posed to substance misuse may show greater excitability 
and irritability (tobacco, cocaine, opiates), low (cocaine) 
or high muscle tone (tobacco, opiates), autonomic and 
central nervous system abnormalities (tobacco, opiates, 
cocaine, marijuana) and require more parent handling 
to settle (tobacco, cocaine, opiates) [11-14]. Other stud-
ies have found prenatal tobacco exposure to be associated 
with deficits in infant affect regulation, attention, and be-
haviour [15,16].
Whilst research to date has not established a causal 
relationship between parental substance misuse and poor 
parenting, it is likely that the relationship is bi-directional 
[4]. Namely, a child’s affect regulation and behavioural 
difficulties may negatively impact the parent-child bond 
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and elicit poor parenting responses; in turn, elevated 
parenting stress and relational difficulties may further 
reinforce offspring regulation and behavioural difficulties. 
Other factors that are commonly associated with a 
substance use lifestyle that may negatively influence this bi-
directional relationship include: exposure to violence and 
criminal activity, poor nutrition, poor physical and sexual 
health, unplanned and unwanted pregnancies, chronic 
substance abuse, polydrug use, poverty, unemployment, 
unstable living arrangements, social isolation and poor 
social support [17-21]. These concomitant factors are 
likely to further increase the risk for poor parenting 
practices, parent-child relational problems and adverse 
child outcomes. Taken together, parents and children 
may become entrenched in a mutually reinforcing cycle 
which exacerbates difficulties and leaves children feeling 
inadequately supported by their parents; and reciprocally, 
parents may feel overwhelmed and experience difficulty 
managing parenting roles and responsibilities.
Aims and Hypotheses
In New South Wales, specialist Drugs in Pregnancy 
Services (DPS) have been established, where multidisci-
plinary teams work collaboratively to promote optimal 
pregnancy, birth, and parenting outcomes for pregnant 
women affected by substance use disorders and their 
families [22,23]. Despite these services having been es-
tablished for several decades, there remains a paucity of 
research in Australia on these women and infants; includ-
ing who attends these services, the nature of their psy-
chosocial and health care needs, and outcomes for both 
women and their offspring. Often these women are diffi-
cult to engage in antenatal care and research, particularly 
if fearful that a newborn might be placed in external care 
arrangements. Improved understanding of these families 
is critical as whilst they represent a small proportion of 
the community, the burden of harm both they, and their 
offspring experience, is substantial. This study aimed to 
document the characteristics of women engaged in a spe-
cialist perinatal and family drug health service in a large 
public hospital in Sydney. In particular, the study will fo-
cus on factors shown to be important with respect to po-
tential psychosocial interventions including demographic 
factors, perinatal depression, anxiety and stress, maternal 
bonding, and perceived parenting stress. It was hypoth-
esised that mothers in this specialist DPS would represent 
a disadvantaged group of women, characterised elevated 
rates of psychological and parenting-related distress, and 
lower mother-to-offspring bonding.
Materials and Methods
Study Design
Participants (N=102) were recruited from the Royal 
Prince Alfred Hospital (RPAH), Sydney, Australia. Of 
these, 36 women recruited from the DPS, formed the sub-
stance-exposed (SE) group and 66 women who attended 
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the general antenatal clinic or birth centre, formed the 
comparison group. Women were eligible to participate in 
the study from conception to 40 weeks gestation. This pe-
riod was selected to include high-risk women who often 
attend antenatal services later in pregnancy as well as un-
planned pregnancies where women were not aware that 
they were pregnant until late in the first or second trimes-
ter. The inclusion criteria were: women being identified as 
pregnant by a medical practitioner; women aged 18 years 
or older; the absence of any known major medical compli-
cations in the mother or the fetus; women who intended 
to be the primary caregiver; women who were considered 
mentally able to complete the interview; and being suf-
ficiently literate in English (able to understand a standard 
English newspaper).
All obstetric patients with a current and / or known 
history of substance abuse or dependence (except iso-
lated nicotine dependence) are routinely referred to the 
DPS which offers women individualised treatment for 
substance use, abuse and associated psychosocial issues 
during pregnancy and the postnatal period. SE women 
were invited to participate by a Perinatal Clinical Nurse 
Consultant at the DPS. Women in the comparison group 
were invited to participate by a researcher at the general 
antenatal clinic or birth centre. Of those approached, 80% 
of comparison and 60% of SE women consented to par-
ticipate. Recruitment was conducted between September 
2007 and December 2009. Face-to-face interviews were 
conducted at the third trimester in pregnancy (baseline). 
At 12 months postpartum (12 month), women partici-
pated in another face-to-face interview in the home. Both 
interviews were conducted by trained researchers. All 
women were reimbursed for the time taken to participate 
at baseline and 12 month.
The research protocol was approved by the Macquarie 
University Ethics Review Committee; the University of 
New South Wales (NSW) Research Ethics Committee and 
the Ethics Review Committee (RPAH Zone) of the Sydney 
South West Area Health Service. 
Measures
Demographics and Substance Use
The interviews assessed: demographics, substance 
use history, obstetric health and history, family planning, 
child protection involvement and postnatal issues. The 
Opiate Treatment Index (OTI)[24]was used to measure 
the extent of substance use based on the last three occa-
sions of use.
Antenatal and Postnatal Maternal Bonding
The mother’s felt bond to her developing fetus was 
measured at baseline using the Maternal Antenatal At-
tachment Scale (MAAS)[25]. The 19-item scale yields a 
global bonding score with high scores reflecting optimal 
bonding. Cut off scores were used to categorise bonding 
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quality, with global scores above 76 rated as “high” and 
below rated as “low” [26]. Mother-to-infant bonding was 
measured using the Maternal Postpartum Attachment 
Scale (MPAS) [27] at 12 months. The MPAS consists of 
19-items and yields a global bonding score, with low 
scores indicating a problematic mother-to-infant bond. 
Maternal Mental Health
 Mental health was measured using the Depression, 
Anxiety and Stress Scales, (DASS-21) [28] and the Edin-
burgh Postnatal Depression Scale (EPDS) [29]. The DASS 
is a 21-item scale which consists of three sub-scales meas-
uring depression, anxiety and stress. The DASS manual 
provides cut off scores for severity rating classification, 
including normal, mild, moderate, severe and extremely 
severe. Women who scored within the normal range were 
classed as “non-depressed, -anxious or –stressed”, and 
women who scored within the mild to extremely severe 
range were classed as “depressed, anxious or stressed” [30]. 
EPDS is a screening measure for depression in the 
perinatal period. The EPDS has been validated for ante-
natal use [31]. The 10-item measure assesses past week 
depressive symptoms. A cut-off score of [13] or more 
was used to indicate “probable minor depression” in the 
antenatal period and 15 or more for “probable major de-
pression”. Postpartum, a cut-off score of 10 or more was 
used for “probable minor depression” and 13 or more for 
“probable major depression” [32]. Participants completed 
the DASS and EPDS at baseline and at 12 months.
Parenting Stress
The Parenting Stress Index (PSI) [33] was used to 
measure stress related to parenting and parent-child inter-
actions and includes 120-items, with three subscales: child 
related stress (47-items), parent related stress (54-items), 
and life related stress (19-items). The child stress and par-
ent stress scores combine to form a total stress score. Scores 
that fall at or above the 85th percentile indicate “clinically 
elevated stress”. The PSI is used for early identification of 
dysfunctional parent-child interactions, parental stress, 
family functioning problems, risk for child abuse and ne-
glect and child custody decisions. Participants completed 
the PSI at 12 months. 
Statistical Analyses
Data analyses were performed using SPSS Statistics 
[34]. To determine whether differences existed between 
SE and comparison women, t-tests were used for continu-
ous variables with means reported. Chi-square analyses 
were used for categorical variables, with odds ratios (OR) 
and 95% confidence intervals (CI) reported. 
Results
Sample Description and Attrition
Results were based on interviews with 102 preg-
nant women (SE group n=36; Comparison group n=66). 
Twenty-five mother-infant dyads in the SE group (69%) 
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and 62 in the comparison group (94%) were retained at 
12 months. Reasons for attrition are presented in Table 1. 
Baseline comparisons indicated that SE women lost to fol-
low-up reported significantly higher baseline depression 
and anxiety scores than SE women who were retained (p 
< 0.05).
Table 1: Reasons for participant attrition at 12 months post partum.
Demographics
SE women were significantly younger, had completed 
fewer years of schooling, were more likely to be single, 
multiparous, unemployed and to identify as Aboriginal 
or Torres Strait Islander than women in the comparison 
group (Table 2).
Table 2: Maternal Demographics.
Note: Mean (SD).
Table 3: Lifetime and past month substance use in pregnancy.
Note: Mean (SD). *Abbreviations: mth=month; **IVDU=Intravenous 
Drug Use.
Reason for Loss SE Group (n=36) ComparisonGroup (n=66)
Unable to locate family 6 0
Mother withdrew 2 2
Family moved interstate 1 0
Family moved overseas 0 2
Child in foster care 2 0
Characteristic SE Group
(n=36)
Comparison
(n=66)
Statistical Comparison 95% CI (OR)
Age 
(in years)
29.0 (5.5) 33.24 (4.1) t(100) = 4.4, p <0.001 -
Education 
(in years)
10.2 (1.6) 11.9 (0.5) t(38) = 6.3, p <0.001 -
% Married or 
defacto 
50 96 X2(1, N=102) = 29.4, p < 
0.001
0.1 (0.0, 0.2)
% Unemployed 78 18 X2(1, N=102) = 60.4, p < 
0.001
15.6 (5.8, 43.0)
% Aboriginal 
or Torres Strait 
Islander
31 0 X2(1, N=101) = 22.3, p < 
0.001
N/A
Substance use SE Group
(n=36)
Comparison
(n=66)
Statistical comparison 95% CI (OR)
Alcohol
% Ever used
% Used last mth*
Days used past 
mth
94.3
22.9
3.6 (3.1)
97.0
48.5
3.4 (2.2)
X2(1, N=101) = 0.4, p= .510
X2(1, N=101) = 6.3, p= .012
t(38) = -0.3, p=.791
0.5 (0.1, 3.8)
0.3 (0.1, 0.8)
-
Tobacco
% Ever used
% Used last mth
Days used past 
mth
97.2
77.8
28.7 (5.2)
63.6
4.5
13.7 (14.8)
X2(1, N=102) = 14.2, p= 
<.001
X2(1, N=102) = 59.1, p= 
<.001  
t(2) = -1.7, p=.220
20.0 (2.6, 155.4)
73.5 (18.1, 297.9)
-
Cannabis
   % Ever used
   % Used last mth
   Days used past 
mth
94.4
36.1
19.5 (11.9)
77.3
0
0
X2(1, N=102) = 5.0, p= .026 
X2(1, N=102) = 27.3, p= 
<.001  
t(35) = -3.6, p=.001
5.0 (1.1, 23.3)
1.6 (1.2, 2.0)
-
Heroin
% Ever used
% Used last mth
Days used past 
mth
72.2
19.4
5.3 (6.9)
4.5
0
0
X2(1, N=102) = 52.4, p= 
<.001
X2(1, N=102) = 13.8, p= 
<.001  
t(35) = -1.7, p=.092
54.6 (13.9, 214.6)
1.2 (1.1, 1.5)
-
Cocaine
% Ever used
% Used last mth
Days used past 
mth
66.7
5.6
1.5 (0.7)
42.4
0
0
X2(1, N=102) = 5.5, p= .019
X2(1, N=102) = 3.7, p= .053  
t(35) = -1.4, p=.183
2.7 (1.2, 6.3)
1.1 (1.0, 1.2)
-
Amphetamine
% Ever used
% Used last mth
Days used past 
mth
82.9
2.9
2
47.0
0
0
X2(1, N=101) = 12.2, p= 
<.001
X2(1, N=101) = 1.9, p= .168  
t(34) = -1.0, p=.324
5.5 (2.0, 14.9)
1.0 (1.0, 1.1)
-
Benzodiazepine
   % Ever used
   % Used last mth
   Days used past 
mth
72.2
13.9
13.6 (15.0)
15.2
0
0
X2 (1, N=102) = 33.2, 
p=<.001
X2(1, N=102) = 9.6, p= .002  
t(35) = -1.6, p=.113
14.6 (5.4, 39.3)
1.2 (1.0, 1.3)
-
IVDU**
   % Injected last 
mth
13.9 0 X2(2, N=102) = 9.6, p= .008  0.3 (0.2, 0.4) 
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Table 4: Mother-to-fetus/infant bonding in pregnancy and 12 months 
postpartum.
Note: Mean (SD).
Substance Use
Twenty-three (63.9%) SE women reported receiving 
treatment for substance dependency in pregnancy, with 
the majority (82.6%) in opioid pharmacotherapy. The fre-
quency of lifetime and recent (past month) substance use 
reported during pregnancy are shown in Table 3. Over half 
(61.1%) of women in the SE group reported polydrug use 
in pregnancy (use of two or more substances, in addition 
to opioid pharmacotherapy). At 12 months postpartum, 
94% of comparison women had consumed alcohol, 11% 
tobacco and 5% cannabis. No other illicit substance use 
was reported. For women in the SE group, rates of sub-
stance use at 12 months were significantly higher (than 
comparison women) for tobacco (93%) and cannabis (54 
%), and also included heroin (22%), benzodiazepines 
(15%) and amphetamines (7%).
Table 5: Maternal mental health in pregnancy and 12 months post-
partum.
Note: Mean (SD). *EPDS, Edinburgh postnatal depression scale. 
†DASS, Depression, anxiety and stress scales.
Mother-to-Fetus/Infant Bonding
During pregnancy, the average (mean) mother-to-
fetus bonding (global attachment) score was significantly 
lower for SE women compared to women in the compari-
Bonding SE Group
(n=34)
Compari-
son
(n=62)
Statistical Comparison 95% CI (OR)
Mother-to-fetus
   Global attachment 50.0 (3.6) 74.8 (6.5) t(60) = 19.6, p <.001 -
   % Low global score 100 53 X2 (1, N=96) = 23.9, p = 
<.001
2.1 (1.6, 2.7)
Mother-to-infant
   Global attachment 
(n=26)
84.2 (6.7)
(n=60)
83.6 (6.1) t(84) = -0.4, p = .692 -
Health measure SE Group
(n=36)
Compari-
son
(n=66)
Statistical Comparison 95% CI (OR)
Antenatal
EPDS* total score 9.4 (6.4) 4.9 (4.4) t(50) = -3.7, p <.001 -
% Probable minor 
depression
32 10 X2 (1, N=96) = 7.7, p = 
.005
4.5 (1.5, 13.5)
% Probable major 
depression
24 3 X2 (1, N=96) = 9.7, p = 
.002
9.2 (1.8, 46.5)
DASS† Depression 10.7 (11.6) 4.2 (4.8) t(42) = -3.2, p =.003 -
  % Depressed 47 19 X2 (1, N=98) = 8.5, p = 
.004
3.7 (1.5, 9.2)
DASS Anxiety 7.0 (6.4) 3.2 (4.9) t(56) = -3.0, p =.004 -
  % Anxious 37 13 X2 (1, N=97) = 7.7, p = 
.005
4.0 (1.5, 11.0)
DASS Stress 13.2 (10.9) 8.1 (7.4) t(52) = -2.4, p =.018 -
  % Stressed 37 13 X2 (1, N=96) = 7.5, p = 
.006
3.9 (1.4, 10.8)
Postpartum (n=26) (n=61)
EPDS total score 8.0 (4.3) 4.2 (4.8) t(85) = -3.5, p = .001 -
% Probable minor 
depression
42 15 X2 (1, N=87) = 7.8, p = 
.005
4.2 (1.5, 12.1)
% Probable major 
depression
12 8 X2 (1, N=87) = 0.2, p = 
.621
1.5 (0.3, 6.6)
DASS Depression 8.3 (9.1) 3.4 (4.8) t(31) = -2.4, p = .025 -
  % Depressed 39 15 X2 (1, N=86) = 5.8, p = 
.016
3.5 (1.2, 10.2)
DASS Anxiety 5.1 (5.6) 1.9 (3.7) t(35) = -2.7, p = .012 -
  % Anxious 19 10 X2 (1, N=87) = 1.5, p = 
.227
2.2 (0.6, 7.9)
DASS Stress 11.2 (8.5) 7.3 (6.6) t(85) = -2.3, p = .024 -
  % Stressed 39 12 X2 (1, N=87) = 8.4, p = 
.004
4.8 (1.6, 14.7)
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son group (Table 4). Notably, all women in the SE group 
reported scores in the “low” mother-to-fetus bonding 
range [26], compared to 53% of women in the comparison 
group. At 12 months postpartum, there were no signifi-
cant differences between women in the SE and compari-
son groups on average (mean) mother-to-infant bonding 
(global attachment) scores.
Maternal Mental Health
During pregnancy mean scores on the EPDS and 
DASS subscales were significantly higher for SE women 
than for women in the comparison group (Table 5). Nota-
bly, SE women were nine times more likely to experience 
‘probable major depression’ and close to five times more 
likely to experience ‘probable minor depression’ than 
women in the comparison group. A similar pattern of re-
sults was identified at 12 months postpartum. Notably, SE 
women were four times more likely to experience ‘prob-
able minor depression’ than women in the comparison 
group. Mean scores on the DASS indicated significantly 
higher levels of depression, anxiety and stress among SE 
women than for comparison women.
Parenting Stress
The average (mean) Child Domain Total Score was 
significantly higher for SE women than for comparison 
women, with higher scores evident on the Distractibility 
/ Hyperactivity, Adaptability, and Demandingness sub-
scales (Table 6). Percentile scores were used to interpret 
respondent’s PSI scores, with percentiles at or above 85 
considered to warrant clinical attention (referred to as 
the clinical range from this point onward). Notably, SE 
women were four times more likely to report scores in the 
clinical range on child Distractibility / Hyperactivity and 
Demandingness; six times more likely to report scores in 
the clinical range on child Adaptability; and eight times 
more likely to report scores in the clinical range on the 
Child Domain Total Score(Table 7). 
The average (mean) Parent Domain Total Score was 
not significantly different between groups. The only sub-
scale that differed significantly between the groups was 
the Competence subscale. SE women scored significantly 
worse than women in the comparison group on the Com-
petence subscale and were six times more likely to report 
scores in the clinical range. Overall, while the mean score 
for both groups fell within the normal range (15th – 80th 
percentile), the Total Stress scale mean was significantly 
higher for SE women. Specifically, women in the SE group 
were almost seven times more likely to have scored in the 
clinical range on the Total Stress scale. 
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Table 6: Parenting stress at 12 months postpartum.
Note: Mean (SD). *Higher scores represent poorer functioning on all 
domains.
Table 7:  Parenting stress at 12 months postpartum: Clinical range.
*Higher scores represent poorer functioning on all domains. 
Discussion
 This study prospectively examined mental health, 
mother-to-fetus/infant bonding and parenting stress in 
a high-risk sample of pregnant women with a diagnosed 
history of substance dependence (SE group). The findings 
demonstrate that these women experience considerable 
psychosocial disadvantage, low bonding to their infant 
in-utero and elevated levels of perinatal depression, anxi-
ety, stress, and perceived parenting stress. These findings 
are consistent with the limited extant research available 
on this high-risk group of women, highlighting the sig-
nificant burden of harm experienced by these women and 
their offspring [18-20].
Pregnant women attending the Perinatal and Family 
Drug Health Service were younger, had completed fewer 
years of schooling, were more likely to be single, multipa-
rous and unemployed, when compared to women attend-
ing the general antenatal service. These characteristics are 
consistent with past research on pregnant women affected 
by substance misuse and disorder [18-20] and are mark-
ers of psychosocial disadvantage, particularly when they 
co-occur [4-6]. Compared to the comparison group, more 
SE women also identified as Aboriginal or Torres Strait Is-
lander, which has been linked to higher rates of substance 
misuse associated with unresolved trauma, separation and 
cultural identity issues, discrimination, and economic and 
social disadvantage [23-35].
Clinical range SE Group
(n=26)
Comparison
(n=61)
Statistical Comparison 95% CI (OR)
Child Domain
  % Distractibility/
Hyperactivity
44 15 X2 (1, N=84) = 7.9, p = .005 4.4 (1.5, 13.2)
% Adaptability 30 7 X2 (1, N=84) = 8.4, p = .004 6.2 (1.6, 24.0)
% Demandingness 22 7 X2 (1, N=84) = 4.0, p = .045 4.0 (1.0, 16.3)
% Child Domain Total Score 22 3 X2 (1, N=84) = 7.5, p = .006 8.2 (1.5, 45.9)
Parent Domain
% Competence 30 7 X2 (1, N=84) = 8.4, p = .004 6.2 (1.6, 24.0)
% Total Stress score 26 5 X2 (1, N=84) = 5.1, p = .005 6.8 (1.5, 30.2)
Parenting stress SE Group
(n=26)
Comparison
(n=61)
Statistical Comparison
Child Domain
Distractibility/ Hyper-
activity
26.9 (4.8) 24.0 (4.1) t(82) = -2.7, p = .009
Adaptability 28.0 (6.9) 23.1 (4.6) t(30) = -3.2, p = .004
Reinforces Parent 8.5 (2.3) 8.0 (2.4) t(82) = -0.9, p = .386
Demandingness 18.0 (4.6) 15.5 (.9) t(82) = -2.4, p = .017
Mood 9.1 (3.2) 9.1 (2.2) t(82) = -0.1, p = .917
Acceptability 11.1 (2.9) 10.5 (3.5) t(82) = -0.9, p = .393
Total Score 101.7 (19.2) 90.2 (5.0) t(82) = -2.9, p = .004
Parent Domain
Competence 32.3 (7.7) 28.0 (5.0) t(29) = -2.5, p = .020
Isolation 15.3 (4.1) 13.7 (4.1) t(82) = -1.7, p = .097
Attachment 11.2 (3.1) 10.6 (2.9) t(82) = -0.8, p = .416
Health 13.7 (4.0) 13.5 (3.5) t(82) = -0.1, p = .885
Role Restriction 20.1 (5.7) 19.5 (5.2) t(82) = -0.5, p = .641
Depression 20.3 (6.3) 18.7 (5.5) t(82) = -1.2, p = .253
Spouse 19.5 (5.4) 18.3 (5.4) t(82) = -0.9, p = .376
Total Score 132.5 (29.5) 122.4 (22.4) t(32) = -1.5, p = .148
Total Stress score 234.1 (46.6) 212.6 (32.9) t(82) = -2.4, p = .020
Life Stress score 11.0 (9.0) 9.1 (7.8) t(82) = -1.0, p = .340
Defensive Responding 38.3 (9.4) 35.3 (9.4) t(82) = -1.3, p = .196
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In regard to reported drug use, the majority of women 
attending the Perinatal and Family Drug Health Service 
(63.9%) received treatment for substance dependency in 
pregnancy, typically opioid pharmacotherapy (82.6%). 
Despite these women being actively engaged in treat-
ment, substance use in pregnancy remained common. 
Notably, more than half (61.1%) reported polydrug use in 
pregnancy (use of two or more substances, in addition to 
opioid pharmacotherapy). In trimester three, past month 
tobacco (77.8%) and cannabis use (36.1%) were common; 
SE women also reported using a range of other substanc-
es, including alcohol (22.9%), heroin (19.4%), cocaine 
(5.6%) and amphetamine (2.9%). In regard the number 
of days used, tobacco and cannabis were used most often 
in this sample. At 12 months postpartum, tobacco use was 
reported by most women (93%), and illicit drug use re-
mained common: cannabis (54%), heroin (22%) and am-
phetamine (7%). Taken together, the majority of women 
in this sample were engaged in treatment for substance 
dependency in pregnancy and also appeared to reduce 
their alcohol and drug use whilst pregnant. However, 
drug use was common in pregnancy, and continued into 
the postpartum period. Given that alcohol and drug use 
in pregnancy are associated with detrimental short- and 
long-term harms to offspring development [6,36,37], re-
search is needed to improve treatment interventions for 
maternal substance use disorders, taking into account the 
complex risk profiles and disadvantage experienced by 
these women.
Maternal bonding in pregnancy was found to be sig-
nificantly lower in the SE group, with all women reporting 
‘low’ bonding to their developing fetus in pregnancy. This 
was a notable finding in the third trimester of pregnancy 
when emotional ties to the fetus are reportedly at their 
highest [38]. It is possible that SE women experienced 
more difficulty accepting their pregnancy given the high 
rates of unplanned pregnancies and late presentations for 
prenatal care seen among women attending specialist ser-
vices, such as DPS [20]. It was interesting to note, however, 
that by 12 months postpartum, mother-to-infant bonding 
scores were similar for both groups of women; most were 
classified as ‘high’, indicating a healthy mother-to-infant 
bond. This change in the SE group is somewhat surpris-
ing given the low bonding scores reported in pregnancy. 
It is possible that actual bonding for these women had not 
improved, but that concerns about child protection issues 
due to the chronicity of their substance use caused SE 
women to respond in a socially desirable manner. Con-
versely, the experience of giving birth and being able to 
physically see and hold their baby may have enabled SE 
women to establish a stronger emotional relationship to 
their infant than was experienced whilst pregnant. This 
would suggest that a history of substance use of a severity 
to warrant referral to DPS does not preclude good out-
comes. The use of observational measures to assess car-
egiving and attachment (i.e., the strange situation, emo-
tional availability scales) may help to distinguish these 
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possible explanations. There may also be selection bias in 
that those mothers who lost custody of their babies or did 
not participate in the 12 month follow-up assessment had 
the lowest bonding scores in pregnancy.
The elevated levels of prenatal depression, anxiety and 
stress among SE women are of concern, given that psycho-
logical distress in pregnancy has been associated with risk 
for preterm delivery and low birth weight [39,40]. Prenatal 
depression and anxiety are also considered major risk fac-
tors for postpartum depression and anxiety [41,42]; our 
results support this view, with consistent scores across the 
perinatal period on the DASS and EPDS in both groups. It 
is plausible that prenatal distress may negatively influence 
maternal bonding to the developing fetus during in preg-
nancy. High postpartum distress, especially depression, 
may have interfered with parenting competence, and has 
been shown to be associated with decreased enjoyment of 
parenting, increased parenting stress, and negative feel-
ings toward the infant [43,44.]
Women in the SE group reported substantially higher 
levels of total parenting stress, parent-related stress, and 
in particular, child-related stress, compared to the com-
parison group. An elevated Child Domain score, relative 
to the Parent Domain and Life Stress scale scores, sug-
gests that SE mothers perceived their infant’s character-
istics to be a major factor contributing to their parenting 
stress [33]. Infant characteristics noted include: overactiv-
ity, restlessness, distractibility, short attention span (dis-
tractibility / hyperactivity); inability to change from one 
task to another without emotional upset, overreaction to 
changes in sensory stimulation and to routines, avoid-
ance of strangers, and difficulty calming the child once 
upset (adaptability); and, excessive crying, clingy behav-
iour or a high frequency of minor problem behaviours 
(demandingness). High scores on these subscales suggest 
that parenting is more difficult due to the child’s activity 
levels and inability to adjust to changes in their physical 
or social environment, which may in turnleave parents 
feeling overwhelmed [33,45,46]. Notably, SE women were 
four to six times more likely to report clinically significant 
problems with distractibility/hyperactivity, adaptability 
and demandingness. These results are also consistent with 
extant neurobehavioural studies which demonstrate that 
prenatally substance exposure neonates experience diffi-
culties with affect regulation, attention, irritability, over-
stimulation and require more parent handling to settle 
[11-16]. These characteristics may heighten the risk for 
parent-infant relationship strain, eliciting poor parent-
ing responses [9]. In addition to child characteristics, SE 
women were more likely to report poorer competence as 
a parent. Low parenting competence, in the context of sig-
nificant disadvantage, may place SE women at increased 
risk for postpartum mental health problems and contin-
ued substance use. 
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There are several limitations to note. First, the sam-
ple comprised a small group of pregnant women engaged 
in a specialist Perinatal and Family Drug Health Clinic 
who agreed to be interviewed. Those engaged in antenatal 
care and who participate in research may not be repre-
sentative of all substance affected women; in particular, 
they may be less affected by substance use and generally 
higher functioning. Women who declined to participate 
cited concerns about confidentiality and access to study 
data, as well as the potential involvement of child protec-
tion services; others did not present at antenatal appoint-
ments or were too intoxicated to participate. Moreover, 
not all women who participated were able to be followed 
up (i.e., they either declined or could not be traced); it is 
possible that these women were more severely affected by 
substance use problems. Second, this study relied on self-
report measures of perceived maternal bonding, rather 
than diagnostic or objective observational measures of 
bonding or attachment security, which may be less prone 
to reporting bias. Retrospective self-report of substance 
use may also have resulted in an underestimation of use. 
Previous research comparing urine toxicology and self-
report measures has demonstrated a propensity to under 
report illicit substance use [47]. It is possible that fear of 
child protection involvement (and potential removal of 
the infant from maternal care) may have led some women 
to under-report substance use (and parenting difficulties).
Nevertheless, some studies have noted high concordance 
between self-report and urine toxicology data in sam-
ples which included representation of substance exposed 
pregnant women [48]. Taken together, the findings of this 
study are likely to underestimate the prevalence and sever-
ity of perinatal mental health issues, mother-infant bond-
ing difficulties, and perceived parenting stress associated 
with substance use in pregnancy. Finally, the study only 
included high-risk pregnant women living in a metropoli-
tan city, whose substance intake predominantly included 
methadone, tobacco, cannabis and alcohol. Our results 
are unlikely to be representative of all substance depend-
ent women (i.e., women in rural areas or affected by dif-
ferent substances).
In conclusion, the results of this study suggest that 
pregnant women affected by substance misuse are at in-
creased risk of low maternal bonding to their developing 
baby in pregnancy, perinatal mental health problems, and 
parenting stress postpartum. It is notable that substance 
affected women experienced these issues despite being en-
gaged with a specialist DPS. Maternal substance use has 
serious implications for offspring, including the direct ef-
fect of the substance in utero, as well as indirect effects via 
the environment. The parent-child bond, including major 
disruptions in caregiving, maternal mental health issues, 
social and economic disadvantage, and elevated parenting 
stress are important environmental factors likely to im-
pact on the developing infant’s health and wellbeing. The 
critical period of early development (first 1,000 days) is 
best supported by a warm, loving, reliable and consistent 
28 29www.avidscience.com
Drug Addiction                                                       Drug Addiction
www.avidscience.com
caregiver who can provide a secure start to life for the in-
fant [49]. This study highlights the importance of special-
ised intervention and treatment programs for SE women 
to not only reduce substance use, but to also address prac-
tical support needs, and to enhance the mother-infant 
bond and parenting competence. Strategies to increase the 
effective use of contraceptives may also be warranted to 
minimise the risk for unintended pregnancies [44]. Other 
strategies may include promoting access to specialised an-
tenatal programs targeting maternal bonding in pregnan-
cy and birth readiness, play groups, postnatal depression 
/ anxiety groups and relationship-based parenting pro-
grams. Assisting these substance affected women to im-
prove their mental health, optimise parent-child relation-
ships, and reduce parenting stress may in turn promote 
better health outcomes for these disadvantaged women 
and their infant offspring.
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